Date Filed | Type | Description |
04/25/2012 |
8-K
| Quarterly results |
04/24/2012 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
04/24/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
04/24/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
04/20/2012 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
04/20/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/20/2012 |
4
| NEMMERS JOSEPH M (Director) has filed a Form 4 on SERACARE LIFE SCIENCES INC |
04/20/2012 |
4
| Tillman Jill (Director) has filed a Form 4 on SERACARE LIFE SCIENCES INC |
04/20/2012 |
4
| HRUSOVSKY E KEVIN (Director) has filed a Form 4 on SERACARE LIFE SCIENCES INC |
04/20/2012 |
4
| O'Connor John J. II (VP, Sales and Marketing) has filed a Form 4 on SERACARE LIFE SCIENCES INC |
04/20/2012 |
4
| Dilling Ronald (VP, Operations) has filed a Form 4 on SERACARE LIFE SCIENCES INC |
04/20/2012 |
4
| Benjamin Kathleen (VP, Human Resources) has filed a Form 4 on SERACARE LIFE SCIENCES INC |
04/20/2012 |
4
| Shea Katheryn (VP, BioServices) has filed a Form 4 on SERACARE LIFE SCIENCES INC |
04/20/2012 |
4
| GOULD GREGORY A (Interim CEO, CFO, Treas & Sec.) has filed a Form 4 on SERACARE LIFE SCIENCES INC
Txns:
| Disposed/sold 237,844 shares
@ $0 Disposed/sold 75,000 options to buy
@ $1.25, valued at
$93.8k
Disposed/sold 46,666 options to buy
@ $3, valued at
$140k
Disposed/sold 23,334 options to buy
@ $3, valued at
$70k
|
|
04/20/2012 |
4
| Olsen David (VP, Corporate Quality) has filed a Form 4 on SERACARE LIFE SCIENCES INC |
04/20/2012 |
4
| McLain Brian (VP, Finance and Controller) has filed a Form 4 on SERACARE LIFE SCIENCES INC |
03/26/2012 |
4
| O'Connor John J. II (VP, Sales and Marketing) has filed a Form 4 on SERACARE LIFE SCIENCES INC |
03/13/2012 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
03/12/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
03/12/2012 |
SC 13G/A
| SERACARE LIFE SCIENCES INC reports a 0% stake in SeraCare Life Sciences, Inc. |
03/09/2012 |
4
| Olsen David (VP, Corporate Quality) has filed a Form 4 on SERACARE LIFE SCIENCES INC
Txns:
| Paid exercise price by delivering 472 shares
@ $3.97, valued at
$1.9k
|
|
03/09/2012 |
4
| Dilling Ronald (VP, Operations) has filed a Form 4 on SERACARE LIFE SCIENCES INC
Txns:
| Paid exercise price by delivering 548 shares
@ $3.97, valued at
$2.2k
|
|
03/09/2012 |
4
| Shea Katheryn (VP, BioServices) has filed a Form 4 on SERACARE LIFE SCIENCES INC
Txns:
| Paid exercise price by delivering 513 shares
@ $3.97, valued at
$2k
|
|
03/09/2012 |
4
| McLain Brian (VP, Finance and Controller) has filed a Form 4 on SERACARE LIFE SCIENCES INC
Txns:
| Paid exercise price by delivering 185 shares
@ $3.97, valued at
$734.5 |
|
03/09/2012 |
4
| Benjamin Kathleen (VP, Human Resources) has filed a Form 4 on SERACARE LIFE SCIENCES INC
Txns:
| Paid exercise price by delivering 355 shares
@ $3.97, valued at
$1.4k
|
|
03/09/2012 |
4
| GOULD GREGORY A (Interim CEO, CFO, Treas & Sec.) has filed a Form 4 on SERACARE LIFE SCIENCES INC
Txns:
| Paid exercise price by delivering 1,119 shares
@ $3.97, valued at
$4.4k
|
|
03/05/2012 |
8-K
| Form 8-K - Current report |
02/27/2012 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
02/22/2012 |
SC 13D/A
| Shkreli Martin reports a 0% stake in SeraCare Life Sciences, Inc. |
02/18/2012 |
PRN
| Bull & Lifshitz, LLP Announces Investigation of SeraCare Life Sciences, Inc. |
02/14/2012 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/13/2012 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|